Time of day | Insulin administration | |||||
---|---|---|---|---|---|---|
Overall | Daytime (6:00–22:00)* | Night-time (22:00–6:00)† | CSII | MDI | ||
n (participants) | 88 | 88 | 87 | 50 | 38 | |
Sensor glucose, mmol/L | ||||||
Mean (SD) | 9.7 (2.0) | 9.9 (2.1) | 9.2 (2.4) | 9.8 (2.0) | 9.6 (1.9) | |
Time in range, hypoglycaemia and hyperglycaemia, hours per day (*per day=16-hour period; †per day=8-hour period) | ||||||
3.9–10 mmol/L | mean (SD) | 12.1 (3.7) | 8.1 (2.6) | 4.1 (1.5) | 12.1 (3.6) | 12.2 (3.8) |
min, max | 3.6, 21.0 | 2.7, 14.3 | 0.8, 7.7 | 4.2, 21.0 | 3.6, 20.0 | |
<3.9 mmol/L | mean (SD) | 2.2 (2.2) | 1.2 (1.3) | 1.0 (1.0) | 2.0 (1.6) | 2.6 (2.8) |
min, max | 0.0, 13.5 | 0.0, 9.0 | 0.0, 5.7 | 0.1, 6.5 | 0.0, 13.5 | |
<3.0 mmol/L | mean (SD) | 0.9 (1.6) | 0.4 (0.9) | 0.5 (0.7) | 0.7 (0.9) | 1.3 (2.2) |
min, max | 0.0, 10.5 | 0.0, 7.0 | 0.0, 4.8 | 0.0, 3.4 | 0.0, 10.5 | |
>10.0 mmol/L | mean (SD) | 9.6 (4.2) | 6.7 (2.9) | 2.9 (1.8) | 9.9 (4.4) | 9.2 (3.9) |
min, max | 0.0, 19.5 | 0.0, 13.1 | 0.0, 7.2 | 0.4, 19.5 | 0.0, 15.4 | |
>13.3 mmol/L | mean (SD) | 5.2 (3.4) | 3.8 (2.5) | 1.5 (1.3) | 5.3 (3.5) | 5.1 (3.3) |
min, max | 0.0, 14.1 | 0.0, 10.2 | 0.0, 5.3 | 0.0, 14.1 | 0.0, 11.6 | |
Frequency of hypoglycaemic and hyperglycaemic events per day (24 hours) | ||||||
<3.9 mmol/L | mean (SD) | 1.3 (1.0) | 1.0 (0.8) | 0.5 (0.4) | 1.2 (0.9) | 1.4 (1.0) |
<3.0 mmol/L | mean (SD) | 0.6 (0.8) | 0.4 (0.6) | 0.3 (0.3) | 0.5 (0.4) | 0.7 (1.1) |
>10.0 mmol/L | mean (SD) | 2.6 (0.8) | 2.3 (0.7) | 0.9 (0.5) | 2.7 (0.8) | 2.6 (0.8) |
>13.3 mmol/L | mean (SD) | 1.8 (0.8) | 1.5 (0.7) | 0.6 (0.4) | 1.8 (0.8) | 1.8 (0.9) |
Overall glucose variability | ||||||
SD, mmol/L | 4.5 (1.1) | 4.5 (1.1) | 4.0 (1.1) | 4.4 (0.9) | 4.6 (1.2) | |
Coefficient of variation (subject level), % | 46.5 (7.8) | 45.7 (8.0) | 43.6 (9.6) | 45.2 (7.7) | 48.2 (8.1) |
CSII, continuous subcutaneous insulin infusion; MDI, multiple daily injection.